Most of the pMMR/MSS CRCs arise via the conventional adenoma–carcinoma sequence, which involves the activation of oncogenes such as KRAS and the inactivation of tumor suppressors, including APC, SMAD4, and TP53 [33,34,35,36]. Here, KRAS is linked to adenoma.